Therapeutics
In this section you will find Therapeutics market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Oncology Drug Pathway Analyzer (Premium Version)
€9,900.00Published by BioSeeker Group on May 23rd, 2012Get instant, interactive modeling on almost 3,000 cancer drugs and affected signaling pathways across close to 90 different cancer types. Learn More -
Oncology Drug Pathway Analyzer (Standard Version)
€6,900.00Published by BioSeeker Group on May 23rd, 2012Get instant, interactive modeling on almost 3,000 cancer drugs and affected signaling pathways across close to 90 different cancer types. Learn More -
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Leukemia, Prostate Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More